secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sarepta Therapeutics, Inc. (SRPT)
CIK:        0000873303
Form:       8-K
Filed at:   2025-08-13T23:59:59+00:00
Accession:  0001193125-25-179819
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sarepta EVP Chief Technical Operations Officer Bilal Arif to depart Sept 16, 2025; severance $576,700
--------------------------------------------------------------------------------

- Bilal Arif's employment ends Sept 16, 2025; served as EVP, Chief Technical Operations Officer until Aug 12.
- He will serve as Special Advisor to the President for the remainder of his employment.
- Severance lump sum of $576,700 plus consulting fee of $400 per hour through Dec 31, 2025.
- Outstanding equity awards continue to vest through employment and consulting period.
- Departure part of strategic restructuring and pipeline prioritization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/873303/000119312525179819/0001193125-25-179819-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/873303/000119312525179819/d59666d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-179819

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer